All News #Library
Quality
Gland Pharma Gets USFDA EIR for Visakhapatnam Facility
24 Jun 2025 //
BUSINESS STD
USFDA Issues Form 483 With 3 Observations To Gland Pharma
12 Mar 2025 //
INDPHARMAPOST
Gland Pharma`s JNPC facility completes USFDA inspection
25 Feb 2025 //
BUSINESS STD
U.S. FDA issues 3 observations to Gland Pharma facility in Hyderabad
02 Aug 2024 //
THEHINDU
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
25 Jul 2024 //
THEHINDU
U.S. FDA issues Form 483 with two observations to Gland Pharma
26 Aug 2023 //
THEHINDU
Gland Pharma`s Hyderabad unit gets one observation from USFDA after inspection
27 Jun 2023 //
ECONOMIC TIMES
Par recalls product after glass particulate contamination
13 May 2019 //
IN -PHARMATECHNOLOGIST
Sagent Pharma Issues Voluntary Recall of Methylprednisolone Sodium Succinate
05 Mar 2018 //
PR NEWSWIRE

Market Place
Sourcing Support